Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Summary

This phase II trial is studying how well ixabepilone works in treating young patients with refractory solid tumors. Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2006-04

Primary completion

2007-10

Completion

2009-06

Drugs

Indications